Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Investigating the Feasibility of Current Gene Targeted Therapeutics for Human Disease
EF 2016-17
Résumé
Targeting and repairing the affected genes of patients with genetic disorders is the most direct way of attempting to remedy their disorder. Targeted gene therapy using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated protein 9 (Cas9) is a rapidly evolving technology with a lot hope for therapeutics in the future. One novel approach to increasing the overall success of this system has been to fuse a deactivated Cas9 protein to a cytosine deaminase. It is predicted that this new technique, which cases a substitution only at targeted cytosine nucleotides, could be an effective therapeutic treatment for patients with more than 300 known genetic diseases. I will evaluate both the potential efficiency and safety of this new system by introducing it into cell culture lines derived from patients with intellectual and skeletal disorders that are caused by recessive biallelic mutations in the N-acetylneuraminic acid synthase (NANS) gene. For comparison, I will also transfect a subset of these cell lines with the previously used CRISPR/Cas 9 method which utilizes the cells' own repair machinery to edit the targeted sequence. I predict that this new system for base editing will have a significantly higher efficiency of targeted base editing than the previous method and will not disturb to the rest of the genome. The results of this experiment are important and necessary because they may help confirm the safety and efficacy of this potential future treatment.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367064
Name
Carlaw Tiffany M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Feasibility of Current Gene Targeted Therapeutics for Human Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crispr/Cas9; Gene Therapy; Genetics; Human Disease
Abstract
Targeting and repairing the affected genes of patients with genetic disorders is the most direct way of attempting to remedy their disorder. Targeted gene therapy using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated protein 9 (Cas9) is a rapidly evolving technology with a lot hope for therapeutics in the future. One novel approach to increasing the overall success of this system has been to fuse a deactivated Cas9 protein to a cytosine deaminase. It is predicted that this new technique, which cases a substitution only at targeted cytosine nucleotides, could be an effective therapeutic treatment for patients with more than 300 known genetic diseases. I will evaluate both the potential efficiency and safety of this new system by introducing it into cell culture lines derived from patients with intellectual and skeletal disorders that are caused by recessive biallelic mutations in the N-acetylneuraminic acid synthase (NANS) gene. For comparison, I will also transfect a subset of these cell lines with the previously used CRISPR/Cas 9 method which utilizes the cells' own repair machinery to edit the targeted sequence. I predict that this new system for base editing will have a significantly higher efficiency of targeted base editing than the previous method and will not disturb to the rest of the genome. The results of this experiment are important and necessary because they may help confirm the safety and efficacy of this potential future treatment.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Carlaw, Tiffany M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~